FDA Device Intelligence
HomeAROA BIOSURGERY LIMITED › Endoform™ Antimicrobial Restorative Bioscaffold

Endoform™ Antimicrobial Restorative Bioscaffold

AROA BIOSURGERY LIMITED · Model 629314 · UDI-DI 09421906017472

FRO Prescription
1
510(k) clearances
3,166
Adverse events (64 deaths)
82
Recalls
383
Facilities

Description

Endoform™ Antimicrobial is a 100% w/w intact extracellular matrix (ECM), manufactured from ovine (sheep) forestomach tissue and incorporating approximately 12 ug/cm2 (~0.3% w/w) ionic silver, intended to inhibit colonization of the device. This advanced wound care device retains the innate biological structure of the native ECM, along with associated macromolecules including elastin, fibronectin, glycosaminoglycans and laminin. When rehydrated with exudate or sterile saline, Endoform Antimicrobial transforms into a soft conforming sheet, which is naturally incorporated into the wound over time.

Recalls

DateFirmReason
2026-06-08ConvaTec, IncSurgical dressing manufactured out of specification (greater thickness).
2026-04-27Oculus Technologies of Mexico, S.A. de C.V.The recall is being conducted due to corrosion of the internal metallic spring within the sprayer component. This condition is caused by material incompatibility between the produc
2026-01-16Integra LifeSciences Corp. (NeuroSciences)Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-16Integra LifeSciences Corp. (NeuroSciences)Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-16Integra LifeSciences Corp. (NeuroSciences)Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-05Medline Industries, LPMedline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for
2026-01-05Medline Industries, LPMedline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for
2025-08-05Integra LifeSciences Corp. (NeuroSciences)Packaging failures were identified which could lead to a breach in the sterile barrier.
2025-08-05Integra LifeSciences Corp. (NeuroSciences)Packaging failures were identified which could lead to a breach in the sterile barrier.
2025-08-05Integra LifeSciences Corp. (NeuroSciences)Packaging failures were identified which could lead to a breach in the sterile barrier.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.